Search Results 2151-2160 of 20273 for menopause

  1. A Study to Assess Effectiveness and Safety of SER‑287 in Adults With Active Mild-to-Moderate Ulcerative Colitis - Mayo Clinic

    Not of childbearing potential, defined as postmenopausal (≥ 12 continuous months of amenorrhea with no other cause than menopause) or surgically sterile ...

  2. Breast cancer - Doctors and departments - Mayo Clinic

    Kok, M.D.. Internist. Rochester, MN. Areas of focus: Sexual dysfunction, Breast cancer, Menopause, Vaginal atrophy, Perimenopause, Breast cysts and lumps, ...

  3. Mayo Clinic Q and A: Understanding adult acne

    Acne occurs when hair follicles become plugged with oil and dead skin cells. Hair follicles are connected to sebaceous glands. Those glands make an oily ...

  4. Talking About Talcum Powder - Mayo Clinic News Network

    Talcum powder is a combination of the mineral talc mixed with powder, often used to absorb moisture and some women use it for feminine hygiene.

  5. Ibandronate (intravenous route) - Side effects & uses - Mayo Clinic

    Ibandronate injection is used to treat osteoporosis (thinning of the bone) in women after menopause. This medicine is to be given only by or under the ...

  6. Publications - Chris A. Aakre, M.D. - Mayo Clinic

    2021 Jan-Dec; 12:21501327211030826. View PubMed; Aakre CA. Fibromyalgia screening in patients with unexplained chronic fatigue. Menopause. 2020 Nov 2; 28 (1): ...

  7. A Study of Ibrutinib as Prophylaxis for Chronic Graft-Versus-Host Disease (GVHD) in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (allo-HCT) - Mayo Clinic

    Female subjects of non-reproductive potential are defined as follows: post-menopausal by history - no menses for ≥1 year; or s/p hysterectomy; or s/p bilateral ...

  8. Benralizumab for Eosinophilic Esophagitis - Mayo Clinic

    Until FSH is documented to be within menopausal range, treat the patient as WOCBP;; Women ≥ 50 years old will be considered postmenopausal if they have been ...

  9. Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery - Mayo Clinic

    Estrogen receptor and progesterone receptor status known. PATIENT CHARACTERISTICS: Male or female; Menopausal status not specified; ECOG performance status 0-2 ...

  10. A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer - Mayo Clinic

    Women must be post-menopausal infertile, or use a reliable means of contraception. Women of childbearing potential must have a negative pregnancy test done ...